| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |